Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
65 | Clinical Pharmacist | journal | 0.109 Q4 | 11 | 0 | 266 | 0 | 38 | 225 | 0.08 | 0.00 | 0.00 | |
64 | Drug and Therapeutics Bulletin | journal | 0.156 Q4 | 17 | 90 | 294 | 1063 | 95 | 193 | 0.42 | 11.81 | 40.91 | |
63 | Drugs and Therapy Perspectives | journal | 0.161 Q4 | 13 | 75 | 270 | 2279 | 218 | 244 | 1.07 | 30.39 | 46.20 | |
62 | Journal of Pharmaceutical Health Care and Sciences | journal | 0.220 Q3 | 10 | 48 | 28 | 1315 | 35 | 28 | 1.25 | 27.40 | 29.27 | |
61 | Expert Opinion on Orphan Drugs | journal | 0.222 Q3 | 27 | 28 | 180 | 1958 | 164 | 170 | 1.02 | 69.93 | 38.89 | |
60 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.254 Q3 | 46 | 49 | 73 | 2216 | 374 | 72 | 4.10 | 45.22 | 38.33 | |
59 | Psychiatry and Clinical Psychopharmacology | journal | 0.313 Q3 | 24 | 59 | 283 | 2281 | 302 | 277 | 1.02 | 38.66 | 48.22 | |
58 | Biopharmaceutics and Drug Disposition | journal | 0.335 Q3 | 65 | 38 | 110 | 1664 | 198 | 109 | 1.77 | 43.79 | 44.90 | |
57 | Journal of Oncology Pharmacy Practice | journal | 0.374 Q3 | 44 | 312 | 724 | 7213 | 1104 | 664 | 1.54 | 23.12 | 51.00 | |
56 | Journal of Chemotherapy | journal | 0.429 Q3 | 56 | 64 | 182 | 2466 | 382 | 171 | 2.20 | 38.53 | 49.64 | |
55 | Human Psychopharmacology | journal | 0.448 Q3 | 86 | 40 | 96 | 1995 | 202 | 96 | 2.44 | 49.88 | 39.54 | |
54 | European Journal of Contraception and Reproductive Health Care | journal | 0.457 Q3 | 53 | 75 | 234 | 2424 | 402 | 204 | 1.73 | 32.32 | 60.22 | |
53 | BMC pharmacology & toxicology | journal | 0.497 Q3 | 43 | 72 | 261 | 2911 | 762 | 261 | 2.52 | 40.43 | 42.04 | |
52 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.517 Q2 | 81 | 232 | 499 | 7126 | 1162 | 465 | 2.35 | 30.72 | 47.35 | |
51 | Fundamental and Clinical Pharmacology | journal | 0.534 Q2 | 85 | 107 | 232 | 5893 | 618 | 207 | 2.74 | 55.07 | 49.13 | |
50 | International Journal of STD and AIDS | journal | 0.537 Q2 | 78 | 185 | 633 | 5635 | 844 | 602 | 1.16 | 30.46 | 50.80 | |
49 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.552 Q2 | 61 | 118 | 225 | 5434 | 530 | 213 | 2.12 | 46.05 | 46.46 | |
48 | HIV Research and Clinical Practice | journal | 0.612 Q2 | 54 | 21 | 66 | 917 | 119 | 65 | 1.54 | 43.67 | 45.54 | |
47 | Pharmaceutical Medicine | journal | 0.617 Q2 | 25 | 37 | 108 | 1011 | 236 | 98 | 2.70 | 27.32 | 49.24 | |
46 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.685 Q2 | 57 | 73 | 187 | 4001 | 505 | 179 | 2.51 | 54.81 | 32.88 | |
45 | Paediatric Drugs | journal | 0.709 Q2 | 70 | 49 | 153 | 3421 | 591 | 147 | 4.17 | 69.82 | 48.57 | |
44 | Clinical Drug Investigation | journal | 0.718 Q2 | 67 | 108 | 364 | 3657 | 1097 | 334 | 3.05 | 33.86 | 39.69 | |
43 | Cardiovascular Therapeutics | journal | 0.725 Q2 | 54 | 37 | 150 | 1540 | 510 | 149 | 3.36 | 41.62 | 44.91 | |
42 | Expert Opinion on Pharmacotherapy | journal | 0.735 Q2 | 93 | 236 | 670 | 18660 | 2242 | 576 | 3.44 | 79.07 | 38.19 | |
41 | Pharmaceutical Statistics | journal | 0.775 Q2 | 46 | 94 | 198 | 2696 | 247 | 184 | 1.01 | 28.68 | 27.70 | |
40 | Therapeutic Advances in Cardiovascular Disease | journal | 0.816 Q2 | 41 | 10 | 75 | 428 | 201 | 66 | 3.11 | 42.80 | 17.14 | |
39 | AIDS Research and Therapy | journal | 0.827 Q2 | 49 | 99 | 134 | 3589 | 377 | 134 | 2.84 | 36.25 | 41.32 | |
38 | Antiviral Therapy | journal | 0.835 Q2 | 93 | 46 | 182 | 879 | 437 | 174 | 1.65 | 19.11 | 52.26 | |
37 | Therapeutic Advances in Drug Safety | journal | 0.837 Q2 | 46 | 35 | 123 | 1607 | 454 | 102 | 2.87 | 45.91 | 44.02 | |
36 | Expert Review of Anticancer Therapy | journal | 0.852 Q2 | 85 | 127 | 346 | 9854 | 1422 | 302 | 3.25 | 77.59 | 46.44 | |
35 | Trials | journal | 0.865 Q2 | 98 | 924 | 2484 | 34482 | 6432 | 2410 | 2.46 | 37.32 | 47.45 | |
34 | Pharmacoepidemiology and Drug Safety | journal | 0.868 Q2 | 109 | 184 | 597 | 6052 | 1500 | 552 | 2.41 | 32.89 | 52.95 | |
33 | Expert Opinion on Drug Safety | journal | 0.882 Q1 | 90 | 143 | 402 | 10125 | 1584 | 369 | 3.78 | 70.80 | 43.21 | |
32 | Expert Review of Clinical Pharmacology | journal | 0.927 Q1 | 60 | 135 | 357 | 10829 | 1505 | 314 | 3.68 | 80.21 | 44.22 | |
31 | HIV Medicine | journal | 0.936 Q1 | 86 | 112 | 321 | 3718 | 828 | 276 | 2.63 | 33.20 | 50.40 | |
30 | Expert Opinion on Emerging Drugs | journal | 0.972 Q1 | 54 | 34 | 91 | 3255 | 366 | 86 | 3.53 | 95.74 | 36.04 | |
29 | American Journal of Cardiovascular Drugs | journal | 1.010 Q1 | 60 | 63 | 164 | 2693 | 622 | 155 | 3.75 | 42.75 | 29.75 | |
28 | Journal of Psychopharmacology | journal | 1.014 Q1 | 135 | 150 | 429 | 9459 | 1885 | 416 | 3.99 | 63.06 | 39.74 | |
27 | Expert Review of Neurotherapeutics | journal | 1.020 Q1 | 98 | 116 | 319 | 12395 | 1318 | 273 | 3.68 | 106.85 | 43.82 | |
26 | Drugs and Aging | journal | 1.048 Q1 | 109 | 89 | 288 | 5473 | 1295 | 279 | 4.39 | 61.49 | 48.95 | |
25 | British Journal of Clinical Pharmacology | journal | 1.055 Q1 | 167 | 496 | 894 | 19557 | 3500 | 759 | 3.50 | 39.43 | 43.92 | |
24 | Orphanet Journal of Rare Diseases | journal | 1.105 Q1 | 136 | 505 | 860 | 19746 | 3756 | 850 | 3.96 | 39.10 | 50.94 | |
23 | Advanced Therapeutics | journal | 1.134 Q1 | 39 | 153 | 233 | 16392 | 1371 | 229 | 5.23 | 107.14 | 39.88 | |
22 | Expert Opinion on Investigational Drugs | journal | 1.177 Q1 | 117 | 116 | 331 | 9002 | 1793 | 313 | 5.43 | 77.60 | 35.43 | |
21 | Therapeutic Advances in Respiratory Disease | journal | 1.219 Q1 | 50 | 49 | 189 | 2024 | 1058 | 179 | 4.99 | 41.31 | 45.33 | |
20 | CNS Drugs | journal | 1.263 Q1 | 129 | 90 | 271 | 6681 | 1610 | 260 | 6.15 | 74.23 | 44.58 | |
19 | Drug Safety | journal | 1.268 Q1 | 140 | 121 | 383 | 4708 | 1757 | 325 | 4.81 | 38.91 | 49.72 | |
18 | Clinical Pharmacokinetics | journal | 1.274 Q1 | 184 | 118 | 360 | 5753 | 2018 | 324 | 5.18 | 48.75 | 41.29 | |
17 | Antimicrobial Resistance and Infection Control | journal | 1.286 Q1 | 66 | 166 | 555 | 6565 | 3476 | 548 | 6.10 | 39.55 | 45.62 | |
16 | CNS Neuroscience and Therapeutics | journal | 1.364 Q1 | 91 | 148 | 405 | 8013 | 2398 | 355 | 6.36 | 54.14 | 40.91 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®